Management of venous malformations in Klippel-Trenaunay syndrome with ultrasound-guided foam sclerotherapy

Phlebology

Volumn 20, Issue 2, 2005, Pages 63-81

  McDonagh, B ^a   Sorenson, S ^a   Cohen, A ^a   Eaton, T ^a   Huntley, D E ^a   La Baer, S ^a   Campbell, K ^a   Guptan, R C ^b  

^a Illinois Phlebology Group   (United States)

^b Venous Research Foundation   (United States)

Author keywords

Capillary lymphatic venous malformation; Chronic venous insufficiency; Foam sclerotherapy; Klippel Trenaunay syndrome; Port wine stain; Ultrasound guided sclerotherapy; Varicose veins; Venous malformation

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ADULT; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; BONE MALFORMATION; CAPILLARY PROLIFERATION; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPASS TECHNIQUE; FAMILY HISTORY; FEMALE; FOAM STABILITY; HUMAN; LEG LENGTH; MALE; OPEN STUDY; PAIN; PAIN ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENCE RISK; SCLEROTHERAPY; SOFT TISSUE DEFECT; THORAX WALL DEFECT; ULTRASOUND GUIDED FOAM SCLEROTHERAPY; VEIN MALFORMATION;

EID: 20844438458     PISSN: 02683555     EISSN: None     Source Type: Journal    
DOI: 10.1258/0268355054069188     Document Type: Article

References (28)

1. Klippel-Trenaunay-Weber Syndrome. National Center for Biotechnology Information (NCBI) 2004; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi7CMD = search&DB = omim#149000
2. Berry SA, Peterson C, Mize W, et al. Klippel-Trenaunay syndrome. Am J Med Genet 1998;79:319-26
3. Cohen MM. Editorial comment: Klippel-Trenaunay syndrome. Am J Med Genet 2000;93:171-5
4. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clinic Proc 1998;73:28-36
5. Hand JL, Frieden IJ. Vascular birthmarks of infancy: resolving nosologie confusion. Am J Med Genet 2002;108:257-64
6. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22
7. Lordia Sanchez I, Rodriquez Pinilla E, Martinez Frias ML. Increased parental age and number of pregnancies in Klippel-Trenaunay-Weber Syndrome. Ann Hum Genet 1998;62:235-9
8. Whelan AJ, Watson MS, Porter FD, Steiner RD. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. Am J Med Genet 1995;59:492-4
9. Wang Q, Timur AA, Szafranski P, et al. Identification and molecular characterization of de novo translocation t(8;14) (q22.3; q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet 2001;95:183-8
10. Tian XL, Kadaba R, You SA, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004;427:640-5
11. Servelle M. Klippel and Trenaunay's syndrome. Ann Surg 1985;201:365-72
12. Noel AA, Gloviczki P, Cherry KJ, Rooke TW, Stanson AW, Driscoll DJ. Surgical treatment of venous malformations in Klippel-Trenaunay syndrome. J Vasc Surg 2000;32:840-7
13. Jackson IT, Carreno R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993;91:1216-30
14. Woods JE. Extended use of sodium tetradecyl sulfate in treatment of hemangiomas and other related conditions. Plastic Reconstr Surg 1987;79:542-9
15. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000;26:323-8
16. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995;2:188-94
17. McDonagh B, Huntley DE, Rosenfeld R, et al. Efficacy of the Comprehensive Objective Mapping, Precise image guided injection, Anti reflux positioning and Sequential Sclerotherapy (COMPASS) technique in the management of greater saphenous varicosities with saphenofemoral incompetence. Phlebology 2002;17:19-27
18. McDonagh B, Sorenson S, Gray C, et al. Clinical spectrum of recurrent postoperative varicose veins and efficacy of sclerotherapy management using the compass technique. Phlebology 2003;18:173-86
19. Tessari L. Nouvelle technique d'obtention de la Scleromousse. Phlebologie 2000;53:129-35
20. Gloviczki P, Stanson AW, Stickler GB, et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 1991;110:469-79
21. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg 1995;82:757-61
22. Kasabach-Merritt Syndrome; KMS, National Center for Biotechnology Information (NCBI) 2004; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD = search&DB = omim#141000
23. Mason KP, Neufeld EJ, Karian VE, et al. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. Am J Roentgenol 2001;177:1359-63
24. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15:431-45
25. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-16
26. Hsu TS, Weiss RA. Foam sclerotherapy: a new era. Arch Dermatol 2003;139:1494-6
27. Yamaki T, Nozaki M, Fujiwara O, Yoshida E. Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 2002;28:619-22
28. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-22 (discussion 722)